Purchase Order HHSD2002017M95077P

Genscript USA Inc. has been awarded a $24,705 firm fixed price purchase order by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to provide services for creating customized monoclonal antibodies and plasmids in support of the agency's biomedical research efforts. As the prime contractor, Genscript will leverage its expertise in gene synthesis and monoclonal antibody development to deliver the requested biological products and services. This contract...

This is a delivery order issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, under the General Services Administration (GSA) Multiple Award Schedule (MAS) contract. The prime contractor is Government Scientific Source Inc. (GSS), a for-profit organization and a leading distributor of laboratory products and equipment serving government agencies. The $13,401.18 firm-fixed-price contract is for the delivery of antibody products. It does not have a...

This is a $97,722.00 firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The contract is for the provision of monoclonal antibodies and plasmids services to support NIAID's research initiatives, with a completion date of September 19, 2025. This contract is not designated as a set-aside....

The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences awarded a $105,669.50 firm fixed price delivery order to A&G Pharmaceutical, Inc., doing business as Precision Antibody, for Task Order 7 under the DOK7 contract vehicle. Precision Antibody will provide custom antibody development services in support of biomedical research at the Center's location in Potomac, Maryland by the stated completion date of March 17, 2025....

This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the U.S. Department of Health and Human Services, to Spring Valley Laboratories, Inc. for the provision of custom polyclonal antibody, polyclonal from exsanguination, and courier charges. The contract, valued at $3,557.61, was awarded on December 18, 2012 with a completion date of December 21, 2012. The contract type is a purchase order with a firm fixed price. There was no...

This federal contract award to Genscript USA Inc., a biotechnology company in Piscataway, New Jersey, is for gene synthesis, expression, and purification services valued at $11,211.10. The contract was awarded by the U.S. Department of Agriculture's (USDA) Agricultural Research Service (ARS) and does not have a set-aside designation. The contract supports the production of recombinant mouse monoclonal IgE antibodies that can recognize and distinguish between nut allergens Ana o 3 and Car i 1....

This $8,435.16 firm fixed price purchase order was awarded by the National Institute of Allergy and Infectious Diseases, part of the Department of Health and Human Services' National Institutes of Health, to Genscript USA Inc., a for-profit biotechnology company located in Piscataway, New Jersey. The contract is for antibody production services, with a completion date of June 15, 2018. Genscript specializes in providing a range of biomedical research and public health products and services to...

This firm fixed price purchase order was awarded by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to Biolegend, Inc. for $21,586.50. The contract is to procure BioLegend's TOTALSEQ antibodies and associated solutions to support single cell RNA sequencing of cerebrospinal fluid samples as part of the agency's ongoing research into characterizing immune cells in multiple sclerosis patients. Only BioLegend can provide the oligonucleotide-tagged...

This firm fixed price purchase order was awarded by the National Institute of Allergy and Infectious Diseases, part of the Department of Health and Human Services, to Adaptive Biotechnologies Corporation (also doing business as Adaptive) for IMMUNOSEQ MMTCRB SERVICE. The contract, valued at $12,200.00, does not have a set-aside designation. Through this award, Adaptive Biotechnologies will provide specialized sequencing and testing services to support HHS research programs. Adaptive...

The U.S. National Institute of Allergy and Infectious Diseases (NIAID) awarded a $14,690 firm fixed-price purchase order to Adaptive Biotechnologies Corporation (doing business as Adaptive) for ImmunoSEQ sequencing services. The contract has an ultimate completion date of December 20, 2024. Adaptive is a commercial provider of immune-driven medicine services and products, and has previously received federal contracts and grants from the Department of Health and Human Services (HHS), Department...